|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
5,524,000 |
Market
Cap: |
570.02(M) |
Last
Volume: |
19,542 |
Avg
Vol: |
40,496 |
52
Week Range: |
$84.55 - $168.51 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
500 |
Total Buy Value |
$0 |
$0 |
$0 |
$100,000 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
0 |
1,500 |
10,500 |
46,373 |
Total Sell Value |
$0 |
$168,540 |
$1,317,035 |
$8,243,267 |
Total People Sold |
0 |
1 |
3 |
8 |
Total Sell Transactions |
0 |
1 |
5 |
25 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Guillemin Evan |
Director |
|
2021-05-17 |
4 |
AS |
$244.25 |
$175,860 |
D/D |
(720) |
30,595 |
|
30% |
|
Sullivan John James |
Director |
|
2021-05-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
6,436 |
30,000 |
|
- |
|
Sullivan John James |
Director |
|
2021-05-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,436 |
26,423 |
|
- |
|
Sullivan John James |
Director |
|
2021-05-06 |
4 |
AS |
$250.05 |
$50,010 |
D/D |
(200) |
32,859 |
|
19% |
|
Sullivan John James |
Director |
|
2021-05-05 |
4 |
AS |
$250.59 |
$25,059 |
D/D |
(100) |
33,059 |
|
21% |
|
Sullivan John James |
Director |
|
2021-05-04 |
4 |
AS |
$250.14 |
$183,853 |
D/D |
(735) |
33,159 |
|
12% |
|
Guillemin Evan |
Director |
|
2021-04-16 |
4 |
AS |
$253.77 |
$182,714 |
D/D |
(720) |
31,315 |
|
6% |
|
Sullivan John James |
Director |
|
2021-04-05 |
4/A |
AS |
$250.76 |
$125,380 |
D/D |
(500) |
33,894 |
|
- |
|
Sullivan John James |
Director |
|
2021-03-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
23,564 |
23,564 |
|
- |
|
Sullivan John James |
Director |
|
2021-03-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,564 |
34,394 |
|
- |
|
Guillemin Evan |
Director |
|
2021-03-16 |
4 |
AS |
$269.48 |
$194,026 |
D/D |
(720) |
32,035 |
|
7% |
|
Sakys John V |
CFO |
|
2021-03-12 |
4 |
S |
$263.84 |
$659,600 |
D/D |
(2,500) |
4,350 |
|
-6% |
|
Sakys John V |
CFO |
|
2021-03-12 |
4 |
OE |
$48.72 |
$165,480 |
D/D |
2,500 |
6,850 |
|
- |
|
Archbold Brian David |
SVP Continuous Improvement |
|
2021-03-11 |
4 |
OE |
$129.10 |
$18,720 |
D/D |
145 |
377 |
|
- |
|
Archbold Brian David |
SVP Continuous Improvement |
|
2021-03-10 |
4 |
S |
$271.78 |
$60,607 |
D/D |
(223) |
154 |
|
-6% |
|
Sullivan John James |
Director |
|
2021-03-01 |
4 |
AS |
$273.94 |
$342,425 |
D/D |
(1,250) |
57,958 |
|
0% |
|
Dinoia Gregory |
SVP Commericial |
|
2021-02-23 |
4 |
S |
$276.75 |
$77,490 |
D/D |
(280) |
840 |
|
2% |
|
Guillemin Evan |
Director |
|
2021-02-16 |
4 |
AS |
$281.52 |
$1,013,472 |
D/D |
(3,600) |
32,755 |
|
-1% |
|
Schmieder John Bradley |
Director |
|
2021-02-10 |
4 |
AS |
$278.23 |
$486,903 |
D/D |
(1,750) |
71,717 |
|
-6% |
|
Sullivan John James |
Director |
|
2021-02-01 |
4 |
AS |
$277.67 |
$347,088 |
D/D |
(1,250) |
59,208 |
|
-5% |
|
Schmieder John Bradley |
Director |
|
2021-01-12 |
4 |
AS |
$285.23 |
$136,055 |
D/D |
(477) |
73,467 |
|
-17% |
|
Sakys John V |
CFO |
|
2021-01-08 |
4 |
OE |
$89.70 |
$89,700 |
D/D |
1,000 |
4,350 |
|
- |
|
Sakys John V |
CFO |
|
2021-01-06 |
4 |
AS |
$290.00 |
$4,640 |
D/D |
(16) |
3,350 |
|
-15% |
|
Sakys John V |
CFO |
|
2021-01-06 |
4 |
OE |
$89.70 |
$1,435 |
D/D |
16 |
3,366 |
|
- |
|
Kelly David M |
Director |
|
2020-12-11 |
4 |
S |
$283.18 |
$70,795 |
D/D |
(250) |
2,350 |
|
8% |
|
176 Records found
|
|
Page 5 of 8 |
|
|